EP
CL icon

Eudaimonia Partners’s Colgate-Palmolive CL Stock Holding History

Eudaimonia Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,010
Closed -$237K – 362
2022
Q4 		$237K Sell
3,010
-194
-6% -$14.5K 0.06% 294
2022
Q3 		$225K Sell
3,204
-4,847
-60% -$380K 0.06% 284
2022
Q2 		$645K Buy
8,051
+4,620
+135% +$361K 0.12% 187
2022
Q1 		$260K Buy
+3,431
New +$272K 0.04% 337
2021
Q3 		$263K Sell
3,481
-1,582
-31% -$126K 0.05% 326
2021
Q2 		$412K Buy
5,063
+350
+7% +$28.6K 0.08% 253
2021
Q1 		$372K Hold
4,713
– – 0.08% 242
2020
Q4 		$403K Sell
4,713
-613
-12% -$50.7K 0.09% 214
2020
Q3 		$411K Sell
5,326
-3,055
-36% -$233K 0.11% 195
2020
Q2 		$614K Buy
8,381
+281
+3% +$20K 0.23% 104
2020
Q1 		$538K Buy
8,100
+272
+3% +$19.2K 0.24% 105
2019
Q4 		$539K Buy
+7,828
New +$534K 0.21% 121

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eudaimonia Partners's CL Position: Q1 2023 in Review

Eudaimonia Partners sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 3,010 shares — an estimated $237K sold.

Eudaimonia Partners first reported a position in CL in Q4 2019 and held it in 12 quarters. The position peaked at $645K in Q2 2022. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

  • Eudaimonia Partners reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
  • Eudaimonia Partners sold 3,010 Colgate-Palmolive shares in Q1 2023, an estimated $237K.
  • Eudaimonia Partners first reported a position in Colgate-Palmolive in Q4 2019 and held it in 12 quarters.
  • Eudaimonia Partners's Colgate-Palmolive position peaked at $645K in Q2 2022.
  • 1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Eudaimonia Partners's 13F filing for Q1 2023, filed 25 Apr 2023.